Deliargyris Efthymios
SEC CIK 1751617 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CTSO | Cytosorbents Corp | Chief Medical Off | 473.0K | $30.0K | — | 6 | 2022-08-10 | 2025-08-08 |
Most active insiders at CTSO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chan Phillip P. | CEO, Dir | $197.5K | — |
| 2 | MARIANI PETER J | CFO | $44.0K | — |
| 3 | Sobel Alan D. | Dir | $15.3K | — |
| 4 | Capponi Vincent | Pres, COO | $12.5K | — |
Deliargyris Efthymios made no open-market trades at CTSO in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-08 | 2025-08-08 | CTSO | Cytosorbents Corp | Deliargyris Efthymios | Chief Medical Off | A - Grant | $0.00 | +70.0K | 473.0K | +17% | $0 |
| D | 2025-01-22 | 2025-01-17 | CTSO | Cytosorbents Corp | Deliargyris Efthymios | Chief Medical Off | X - OptEx | $1.00 | +16.2K | 403.0K | +4% | +$16.2K |
| D | 2024-04-04 | 2024-04-02 | CTSO | Cytosorbents Corp | Deliargyris Efthymios | Chief Medical Off | A - Grant | $0.00 | +61.0K | 409.4K | +18% | $0 |
| D | 2023-12-15 | 2023-12-13 | CTSO | Cytosorbents Corp | Deliargyris Efthymios | Chief Medical Off | P - Purchase | $1.33 | +22.6K | 348.4K | +7% | +$30.0K |
| D | 2023-07-11 | 2023-07-07 | CTSO | Cytosorbents Corp | Deliargyris Efthymios | Chief Medical Off | A - Grant | $0.00 | +55.0K | 331.6K | +20% | $0 |
| DM | 2022-08-12 | 2022-08-10 | CTSO | Cytosorbents Corp | Deliargyris Efthymios | Chief Medical Off | A - Grant | $0.00 | +107.0K | 228.4K | +88% | $0 |
Purchase Sale Sale after option exercise All abbreviations